Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening

Table 5 multivariate analyses of factors predicting higher Gleason score on biopsies

Variable	Odds ratio estimates
Variable	Point estimate	95% Confidence interval	P-Value
Post USPSTF recommendation	2.006	1.477–2.725	<.0001
Post CTFPHC recommendation	1.359	0.980–1.868	0.058
Age at diagnosis	1.047	1.032–1.063	<.0001
Baseline PSA	1.074	1.032–1.063	<.0001
Baseline prostate volume	0.990	0.983–0.997	0.006
Baseline PSA density	1.181	0.596–2.343	0.633
Number of cores per biopsy	1.035	0.953–1.124	0.409
TRUS operator (Urologist versus Radiologist)	1.326	0.989–1.778	0.060
Pathology reviewer (F.B. versus others)	1.013	0.793–1.294	0.916

ISSN: 1471-2490